{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:45:23Z","timestamp":1759009523660},"reference-count":25,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Mumps virus infection is a potentially serious viral infection of childhood and early adulthood. In China, live, attenuated S\n            <jats:sub>79<\/jats:sub>\n            mumps virus vaccine has been licensed for pediatric use since 1990. There has been no assessment of its efficacy. Thus, the objective of this study was to determine the effectiveness of live, attenuated S\n            <jats:sub>79<\/jats:sub>\n            mumps virus vaccine against clinical mumps. Cases were selected from the China Information System for Disease Control and Prevention during September 2004 to March 2005. Each case was matched to a control by gender, age, and area of residency. In all, 469 cases and 469 controls were enrolled in the study. Vaccination information was obtained from the Children's EPI Administrative Computerized System. Vaccine effectiveness (VE) was calculated for one or two doses of S\n            <jats:sub>79<\/jats:sub>\n            vaccine, with 95% confidence intervals (CI). VE of mumps virus vaccine for one dose versus none was protection of 86.0% (95% CI, 77.2% to 91.5%) of recipients, and VE was much higher in the first 4 years than in the 5 to 12 years after vaccination. The S\n            <jats:sub>79<\/jats:sub>\n            vaccine can effectively prevent clinical mumps, and a second dose of mumps virus vaccine is necessary for the protection of children in China.\n          <\/jats:p>","DOI":"10.1128\/cvi.00122-08","type":"journal-article","created":{"date-parts":[[2008,7,31]],"date-time":"2008-07-31T01:45:41Z","timestamp":1217468741000},"page":"1425-1428","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Matched Case-Control Study of Effectiveness of Live, Attenuated S\n            <sub>79<\/sub>\n            Mumps Virus Vaccine against Clinical Mumps"],"prefix":"10.1128","volume":"15","author":[{"given":"Chuanxi","family":"Fu","sequence":"first","affiliation":[{"name":"Guangzhou Center for Disease Control and Prevention, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liang","sequence":"additional","affiliation":[{"name":"Guangzhou Center for Disease Control and Prevention, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Guangzhou Center for Disease Control and Prevention, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/587105","volume":"46","year":"2008","unstructured":"Baum, S. G. 2008. Who cares about mumps? You should! Clin. Infect. Dis.46:1450-1451.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/522286","volume":"45","year":"2007","unstructured":"Bernaola, E., M. Herranz, N. Clerigue, and G. Gil. 2007. Case-control studies to assess vaccine effectiveness? Yes, but not this way. Clin. Infect. Dis.45:1240-1241.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/520027","volume":"45","year":"2007","unstructured":"Brunell, P. 2007. The effectiveness of evaluating mumps vaccine effectiveness. Clin. Infect. Dis.45:467-469.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_5_2","first-page":"1","volume":"55","year":"2006","unstructured":"Centers for Disease Control and Prevention. 2006. Mumps epidemic\u2014Iowa 2006. MMWR Dispatch.55:1-3.","journal-title":"MMWR Dispatch."},{"key":"e_1_3_2_6_2","first-page":"175","volume":"55","year":"2006","unstructured":"Centers for Disease Control and Prevention. 2006. Mumps epidemic\u2014United kingdom, 2004-2005. MMWR Morb. Mortal. Wkly. Rep.55:175-177.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1996.03530290060038","volume":"275","year":"1996","unstructured":"Clemens, J., R. Brenner, M. Rao, N. Tafari, and C. Lowe. 1996. Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA275:390-397.","journal-title":"JAMA"},{"key":"e_1_3_2_8_2","first-page":"12","volume":"13","year":"2007","unstructured":"Cohen, C., J. M. White, E. J. Savage, J. R. Glynn, Y. Choi, N. Andrews, D. Brown, and M. E. Ramsay. 2007. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg. Infect. Dis.13:12-17.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","volume":"358","year":"2008","unstructured":"Dayan, G. H., M. P. Quinlisk, A. A. Parker, A. E. Barskey, M. L. Harris, J. M. Schwartz, K. Hunt, C. G. Finley, D. P. Leschinsky, A. L. O'Keefe, J. Clayton, L. K. Kightlinger, E. G. Dietle, J. Berg, C. L. Kenyon, S. T. Goldstein, S. K. Stokley, S. B. Redd, P. A. Rota, J. Rota, D. Bi, S. W. Roush, C. B. Bridges, T. A. Santibanez, U. Parashar, W. J. Bellini, and J. F. Seward. 2008. Recent resurgence of mumps in the United States. N. Engl. J. Med.358:1580-1589.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00103-007-0195-9","volume":"50","year":"2007","unstructured":"Enders, M., M. Biber, and S. Exler. 2007. Measles, mumps and rubella virus infection in pregnancy. Possible adverse effects on pregnant women, pregnancy outcome and the fetus. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz50:1393-1398.","journal-title":"undesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1016\/j.vaccine.2007.10.036","volume":"25","year":"2007","unstructured":"Fu, C., M. Wang, J. Liang, T. He, D. Wang, and J. Xu. 2007. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine25:8756-8761.","journal-title":"Vaccine"},{"key":"e_1_3_2_12_2","first-page":"391","year":"2004","unstructured":"Gershon, A. 2004. Mumps, p. 391-402. In A. Gershon, P. Hotez, and S. Katz (ed.), Krugman's infectious diseases of children, 11th ed. Mosby, Philadelphia, PA.","journal-title":"Krugman's infectious diseases of children"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1016\/j.vaccine.2004.10.020","volume":"23","year":"2005","unstructured":"Harling, R., J. M. White, M. E. Ramsay, K. F. Macsween, and C. van den Bosch. 2005. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine.23:4070-4074.","journal-title":"Vaccine."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","volume":"371","year":"2008","unstructured":"Hviid, A., S. Rubin, and K. M\u00fchlemann. 2008. Mumps. Lancet371:932-944.","journal-title":"Lancet"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1542\/peds.2006-2252","volume":"118","year":"2006","unstructured":"Katz, S. L. 2006. Has the measles-mumps-rubella vaccine been fully exonerated? Pediatrics118:1744-1745.","journal-title":"Pediatrics"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0212-6567(00)78478-2","volume":"25","year":"2000","unstructured":"L\u00f3pez Hern\u00e1ndez, B., R. M. Mart\u00edn V\u00e9lez, C. Rom\u00e1n Garc\u00eda, I. Pe\u00f1alver S\u00e1nchez, and J. A. L\u00f3pez Rosique. 2000. An epidemic of mumps: a study of vaccine efficacy. Aten. Primaria25:148-152.","journal-title":"Aten. Primaria"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1503\/cmaj.070823","volume":"177","year":"2007","unstructured":"MacDonald, N., and K. Flegel. 2007. Mumps in young adults: the canary in the coal mine. CMAJ177:121-123.","journal-title":"CMAJ"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/j.vaccine.2008.04.075","volume":"26","year":"2008","unstructured":"Marin, M., P. Quinlisk, T. Shimabukuro, C. Sawhney, C. Brown, and C. W. Lebaron. 2008. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students\u2014Iowa, 2006. Vaccine26:3601-3607.","journal-title":"Vaccine"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(06)69614-1","volume":"368","year":"2006","unstructured":"O'Brien, K. L., and O. S. Levine. 2006. Effectiveness of pneumococcal conjugate vaccine. Lancet368:1469-1470.","journal-title":"Lancet"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","volume":"45","year":"2007","unstructured":"Peltola, H., P. S. Kulkarni, S. V. Kapre, M. Paunio, S. S. Jadhav, and R. M. Dhere. 2007. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin. Infect. Dis.45:459-466.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1201-9712(02)90162-1","volume":"6","year":"2002","unstructured":"Pugh, R. N., B. Akinosi, S. Pooransingh, J. Kumar, S. Grant, E. Livesley, J. Linnane, and S. Ramaiah. 2002. An outbreak of mumps in the metropolitan area of Walsall, UK. Int. J. Infect. Dis.6:283-287.","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_22_2","first-page":"569","volume":"18","year":"2003","unstructured":"Richard, J. L., M. Zwahlen, M. Feuz, H. C. Matter, and Swiss Sentinel Surveillance Network. 2003. Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case-cohort study. Eur. J. Epidemiol.18:569-577.","journal-title":"Eur. J. Epidemiol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1542\/peds.2006-3451","volume":"120","year":"2007","unstructured":"Schaffzin, J. K., L. Pollock, C. Schulte, K. Henry, G. Dayan, D. Blog, and P. Smith. 2007. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics120:e862-e868.","journal-title":"Pediatrics"},{"key":"e_1_3_2_24_2","first-page":"249","volume":"30","year":"2007","unstructured":"Stock, I. 2007. Mumps\u2014-infectious disease with various faces. Med. Monatsschr. Pharm.30:249-256.","journal-title":"Med. Monatsschr. Pharm."},{"key":"e_1_3_2_25_2","first-page":"418","volume":"44","year":"2005","unstructured":"WHO. 2005. Global status of mumps immunization and surveillance. Wkly. Epidemiol. Rec.44:418-424.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_26_2","first-page":"215","volume":"19","year":"1999","unstructured":"Xu, H., and Q. Tang. 1999. Partial nucleotide sequence analysis of vaccine and wild mumps viruses. Chin. J. Microbiol. Immunol.19:215-218.","journal-title":"Chin. J. Microbiol. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00122-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00122-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:41:03Z","timestamp":1627591263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00122-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1128\/CVI.00122-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00122-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"2008-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}